Pill with imprint 93 541 is Brown / Red, Capsule-shape and has been identified as Cephalexin Monohydrate 250 mg. It is supplied by Teva Pharmaceuticals USA.

Cephalexin is used in the treatment of Bladder Infection; Bacterial Infection; Bacterial Endocarditis Prevention; Bone infection; Kidney Infections and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy. Cephalexin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).